Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A structure of human Scap bound to Insig-2 suggests how their interaction is regulated by sterols
Renhong Yan, Pingping Cao, Wenqi Song, et al.
Science (2021) Vol. 371, Iss. 6533
Open Access | Times Cited: 68

Showing 26-50 of 68 citing articles:

Cholesterol metabolism regulator SREBP2 inhibits HBV replication via suppression of HBx nuclear translocation
Fan Yang, Feng Hu, Hongxiao Song, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
The molecular mechanism underlying the human glucose facilitators inhibition
Cynthia Quan, Xin Jiang
Vitamins and hormones (2025), pp. 49-92
Closed Access
Cholesterol Sulfate as a Negative Regulator of Cellular Cholesterol Homeostasis
Le Ba Nam, Sungjin Kim, Tấn Khanh Nguyễn, et al.
Molecules and Cells (2025), pp. 100209-100209
Open Access
Mechanism and therapeutic potential of liver injury induced by cholesterol-associated proteins
Yourong Zhou, Yashi Cao, Yiming Yin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Insulin-induced gene 2 alleviates ischemia-reperfusion injury in steatotic liver by inhibiting GPX4-dependent ferroptosis
Yichao Wu, Changbiao Li, Di Lu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Understanding the Link Between Sterol Regulatory Element Binding Protein (SREBPs) and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Pervej Alom Barbhuiya, Ren Yoshitomi, Manash Pratim Pathak
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
SREBP2 as a central player in cancer progression: potential for targeted therapeutics
Ruiqi Chen, Tianyu Chen, Xiang Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cholesterol metabolism and its role in type 2 diabetes mellitus development
Gongwen Luo, Minglu Niu, Yan Li, et al.
Food, Nutrition and Health. (2025) Vol. 2, Iss. 1
Open Access
Scap structures highlight key role for rotation of intertwined luminal loops in cholesterol sensing
Daniel L. Kober, Arun Radhakrishnan, Joseph L. Goldstein, et al.
Cell (2021) Vol. 184, Iss. 14, pp. 3689-3701.e22
Open Access | Times Cited: 24
Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages
Yingchun Wang, Yuzhen Wang, Lu Ding, et al.
Cell Reports (2022) Vol. 41, Iss. 9, pp. 111738-111738
Closed Access | Times Cited: 18
Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis
Zeyu Dong, Fangzhou He, Xiaosong Yan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 13, Iss. 4, pp. 1161-1179
Open Access | Times Cited: 16
Studies in the antiviral molecular mechanisms of 25-hydroxycholesterol: Disturbing cholesterol homeostasis and post-translational modification of proteins
Shijie Mao, Jie Ren, Ying Xu, et al.
European Journal of Pharmacology (2022) Vol. 926, pp. 175033-175033
Open Access | Times Cited: 16
Synthesis, function, and regulation of sterol and nonsterol isoprenoids
Rebecca A. Faulkner, Youngah Jo
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 16
25-hydroxycholesterol: an integrator of antiviral ability and signaling
Jialu Zhang, Yaohong Zhu, Xiao‐Jia Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation
Diandra Zipinotti dos Santos, Mohamad Elbaz, Emily Branchard, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116934-116934
Open Access | Times Cited: 3
A fungal tolerance trait and selective inhibitors proffer HMG-CoA reductase as a herbicide mode-of-action
Joel Haywood, Karen J. Breese, Jingjing Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14
miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis
Ya‐Di Wang, Liang-Liang Wu, Yun-Ni Mai, et al.
Metabolism (2023) Vol. 146, pp. 155660-155660
Closed Access | Times Cited: 8
The Hypolipidemic Effect of Hawthorn Leaf Flavonoids through Modulating Lipid Metabolism and Gut Microbiota in Hyperlipidemic Rats
Huiming Hu, Jiajun Weng, Can Cui, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-30
Open Access | Times Cited: 13
Dispatching plasma membrane cholesterol and Sonic Hedgehog dispatch: two sides of the same coin?
Kristina Ehring, Kay Grobe
Biochemical Society Transactions (2021) Vol. 49, Iss. 5, pp. 2455-2463
Open Access | Times Cited: 16
Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy
Ashwini D. Jagdale, Mukul M Angal, Rahul Patil, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116513-116513
Closed Access | Times Cited: 2
Sterol regulation of developmental and oncogenic Hedgehog signaling
Vikas Daggubati, David R. Raleigh, Navdar Sever
Biochemical Pharmacology (2021) Vol. 196, pp. 114647-114647
Open Access | Times Cited: 14
PI(4,5)P2 and Cholesterol: Synthesis, Regulation, and Functions
Avia Rosenhouse‐Dantsker, Dimitris Gazgalis, Diomedes E. Logothetis
Advances in experimental medicine and biology (2023), pp. 3-59
Closed Access | Times Cited: 5
A genome-wide association analysis of 2,622,830 individuals reveals new pathogenic pathways in gout
Tanya J. Major, Riku Takei, Hirotaka Matsuo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Insulin-induced gene 2 protects against hepatic ischemia–reperfusion injury via metabolic remodeling
Yichao Wu, Changbiao Li, Abid Khan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
SREBPs as the potential target for solving the polypharmacy dilemma
Xue Wang, Yanqiu Chen, Heyu Meng, et al.
Frontiers in Physiology (2024) Vol. 14
Open Access | Times Cited: 1

Scroll to top